featured
Adding Cetuximab to Chemoradiotherapy Does Not Improve Esophageal Cancer Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Results and Recurrence Patterns From SCOPE-1: A Phase II/III Randomised Trial of Definitive Chemoradiotherapy +/- Cetuximab in Oesophageal Cancer
Br. J. Cancer 2017 Feb 14;[EPub Ahead of Print], T Crosby, CN Hurt, S Falk, S Gollins, J Staffurth, R Ray, JA Bridgewater, JI Geh, D Cunningham, J Blazeby, R Roy, T Maughan, G Griffiths, S MukherjeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.